Janssen’s Sarich: Randomized Controlled Trials, Real-World Evidence Go Best Together

Janssen’s Troy Sarich outlines why it’s hard to emulate randomized controlled trials with real-world evidence studies, emphasizing that the two are “not in competition.” He also highlights the huge strides made by AI-driven technology firms to provide “research-ready” structured data and new game-changing advances in the area of health sensors.

Clinical Trial Research
• Source: Alamy

Pharma has stepped up its efforts around utilizing real-world data for drug approvals, but reproducing randomized controlled trials (RCTs) using real-world evidence (RWE) is challenging and the two are “not in competition” and complementary, a senior Janssen Pharmaceuticals Inc. executive has emphasized.

Addressing the Indegene Digital Summit, Janssen’s Chief Commercial Data Science Officer Troy Sarich indicated that while there’s been increasing use...

More from Outlook Archive

More from Outlook